Dimensional Fund Advisors
INDV icon

Dimensional Fund Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

Dimensional Fund Advisors’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.6M Buy
1,332,128
+213,959
+19% +$7.07M 0.01% 1611
2025
Q4 		$40.1M Buy
1,118,169
+515,424
+86% +$15.7M 0.01% 1621
2025
Q3 		$14.5M Buy
+602,745
New +$12.6M ﹤0.01% 2149

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors's INDV Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Indivior Pharmaceuticals (INDV) stake by 19% in Q1 2026, buying an estimated $7.07M and bringing the position to 1,332,128 shares worth $40.6M. The position accounts for 0.01% of the portfolio, ranked #1611.

Dimensional Fund Advisors first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Dimensional Fund Advisors held 1,332,128 shares of Indivior Pharmaceuticals worth $40.6M as of Q1 2026.
  • Dimensional Fund Advisors bought 213,959 Indivior Pharmaceuticals shares in Q1 2026, an estimated $7.07M.
  • Indivior Pharmaceuticals made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1611 holding.
  • Dimensional Fund Advisors first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.